Profound Medical Corp (PROF): Market Cap to Revenue

Symbol and logo of brand Profound Medical Corporation (PROF)

The competitive advantage of Profound Medical Corp. (PROF) is based on clinical efficacy and the training of physicians in prostate therapy methods. By analyzing the price-to-sales ratio on GURU.Markets, we observe that 11.60 reflects the baseline level of this metric. Growth potential is driven by high-margin consumables and a unique synthesis of software and hardware patents, which create significant barriers to entry for new players in the robotic ablation segment.

PROF Profound Medical Corporation P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Profound Medical Corp. (PROF)

- share price and consensus valuation forecast:
Price Performance Chart profoundmedical.com|PROF - Price Target Chart
- stock exchange capitalization data:
Market Valuation Profound Medical Corporation|PROF - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Profound Medical|PROF - Book Capitalization|Capitalization to Book Value Ratio profoundmedical.com|PROF - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Profound Medical Corp.|PROF - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio profoundmedical.com|PROF - Company Aggregate Debts|Debts to Book Capitalization Profound Medical Corporation|PROF - Company Long-Term Debt|Company Short-Term Debt Profound Medical|Intermediate Coverage Ratio profoundmedical.com
- earnings and multiples data:
PROF - Net Profit|Expected Net Profit Profound Medical Corp.|PROF - Price to Earnings Ratio|Forward Price to Earnings Multiple profoundmedical.com|PROF - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Profound Medical Corporation|PROF - Operating profit EBITDA|Net earnings per share for the last four quarters Profound Medical|PROF - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months profoundmedical.com|PROF - Earnings per share growth in current year|Expected earnings per share growth for next year Profound Medical Corp.
- issuer revenue and sales details:
PROF - Revenue and Sales Volume|Company Expected Sales Volume profoundmedical.com|PROF - Price-to-Revenue Ratio|Market Cap to Projected Revenue Profound Medical Corporation
General company analysis:PROF Profound Medical Corp
Core merchandise of Profound Medical

To identify undervalued assets, an investor must compare market capitalization with the actual cash flow from sales. This multiple measures the cost per unit of revenue, which is critically important for Profound Medical Corp. (PROF) when assessing the adoption rates of the TULSA-PRO system and the growth of consumables sales, reflecting the current market revaluation through the company's smoothed P/S ratio.

Competitors of Profound Medical Corp.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Price-to-Revenue Multiple|Apyx Medical Corporation - Market Cap to Revenue|P/S Multiple IceCure Medical Ltd. ICCM|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|Profusa Inc (PFSA) - Price-to-Revenue Ratio|Price-to-Sales Ratio SSKN (STRATA Skin Sciences, Inc.)|Price-to-Revenue Ratio GlucoTrack, Inc.|NAOV: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Venus Concept Corp (VERO)|NUWE - Price to Sales|P/S Multiple AEMD (Aethlon Medical)|ASXC (Asensus Surgical Inc) - Price-to-Sales Ratio|AVGR - Price-to-Revenue Ratio|Price to Sales BioSig|CUTR (Cutera, Inc) - Market Cap to Revenue|Know Labs Corporation (KNW) - P/S Multiple|Price-to-Revenue Ratio Inari Medical, Inc.|Market Cap to Revenue Ratio NVRO (nevro.com)|P/S Multiple RSLS|Silk Road Medical, Inc. - Market Cap to Revenue Ratio